指南与共识甲状腺与浅表介入US

2022台湾甲状腺射频消融临床多中心专家共识与建议

2022 Taiwan clinical multicenter expert consensus and recommendations for thyroid radiofrequency ablation.
指南 / 共识 · Ultrasonography · 2022-11-19

台湾介入放射、内分泌及内分泌外科专家采用改良Delphi法,基于文献综述与专家意见制定首部甲状腺射频消融共识。共识涵盖适应证、术前评估、操作技术、术后监测、疗效与安全性,为临床实践提供综合建议。

要点

  • 射频消融可作为良性及复发性恶性甲状腺病变的手术替代方案。
  • 共识涵盖适应证、术前评估、操作技术、术后监测、疗效与安全性。
  • 采用改良Delphi法达成共识,整合文献与专家意见。

核心结论

  • 甲状腺射频消融是良性及复发性恶性甲状腺病变的微创治疗选择,可作为手术替代方案。

研究设计与样本

  • 台湾介入放射、内分泌及内分泌外科相关学术团体成员协作制定共识。
  • 采用改良Delphi法达成共识,基于近期有价值文献的综合回顾与专家意见。

临床应用与阅片要点

  • 共识建议涵盖适应证、术前评估、操作技术、术后监测、疗效与安全性,可用于规范甲状腺射频消融临床实践。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Radiofrequency ablation (RFA) is a minimally invasive management strategy that has been widely applied for benign and recurrent malignant thyroid lesions as an alternative to surgery in Taiwan. Members of academic societies for specialists in interventional radiology, endocrinology, and endocrine surgery collaborated to develop the first consensus regarding thyroid RFA in Taiwan. The modified Delphi method was used to reach a consensus. Based on a comprehensive review of recent and valuable literature and expert opinions, the recommendations included indications, pre-procedural evaluations, procedural techniques, post-procedural monitoring, efficacy, and safety, providing a comprehensive review of the application of RFA. The consensus effectively consolidates advice regarding thyroid RFA in clinical practice for local experts.

来源:Ultrasonography,查看原文。版权归原作者所有。

引用

  1. Lin, Chen, Wang, et al. 2022 Taiwan clinical multicenter expert consensus and recommendations for thyroid radiofrequency ablation. Ultrasonography. 2022. PMID: 37072152. doi:10.14366/usg.22126

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。